详情页 - 首都医科大学宣武医院知识库

当前位置：首页 > 详情页

Cranioplasty after decompressive craniectomy in hemorrhagic moyamoya disease

文献详情

资源类型：

收录情况： ◇ SCIE

作者：

机构： [a]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [b]China National Clinical Research Center for Neurological Diseases, Beijing, China [c]Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China [d]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China [e]Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing, China [f]Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China

出处：

DOI：

ISSN：

关键词： Cranioplasty Decompressive craniectomy Hemorrhage Moyamoya disease Spontaneous revascularization

摘要：

The objective of this study was to investigate cranioplasty after decompressive craniectomy in hemorrhagic moyamoya disease (MMD). We retrospectively reviewed seven patients with hemorrhagic MMD after decompressive craniectomy from January 1, 2010 to December 31, 2018. Clinical features, radiological findings, and outcomes were analyzed. The study included four females and three males, with a mean age at diagnosis of 38.7 years (range 19–56 years). The mean days between craniectomy and DSA was 255 days (with a range of 92–382 days). Three in seven patients had good spontaneous revascularization, while four patients had poor spontaneous revascularization. For patients with good spontaneous revascularization, the computer-assisted design titanium implants for cranioplasty was cut off on the lower edge of the bone window, and all three patients had no complications after cranioplasty and had relatively stable prognosis. For patients with poor spontaneous revascularization, only two patients received cranioplasty. And one in those had unfavorable outcome because of recurrent hemorrhage. In conclusion, spontaneous revascularization after decompressive craniectomy in MMD patients should be evaluated before cranioplasty, and postoperative treatment should be discussed individually. © 2019

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2018]版：

大类 | 4 区医学

小类 | 4 区临床神经病学 4 区神经科学

最新[2023]版：

大类 | 4 区医学

小类 | 4 区临床神经病学 4 区神经科学

JCR分区：

出版当年[2017]版：

Q4 NEUROSCIENCES Q4 CLINICAL NEUROLOGY

最新[2023]版：

Q3 CLINICAL NEUROLOGY Q4 NEUROSCIENCES

影响因子： 1.9 最新[2023版] 1.9 最新五年平均 1.64 出版当年[2017版] 1.573 出版当年五年平均 1.557 出版前一年[2016版] 1.593 出版后一年[2018版]

第一作者：

第一作者机构： [a]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [b]China National Clinical Research Center for Neurological Diseases, Beijing, China [c]Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China [d]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China [e]Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing, China

通讯作者：

通讯机构： [a]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [b]China National Clinical Research Center for Neurological Diseases, Beijing, China [c]Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China [d]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China [e]Beijing Translational Engineering Center for 3D Printer in Clinical Neuroscience, Beijing, China [f]Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China [*1]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

Cranioplasty after decompressive craniectomy in hemorrhagic moyamoya disease

文献详情

相关文献